| Turkish Journal of Cancer |
| 1994, Volume 24, Number 1, Page(s) 38-43 |
|
[ Summary ]
|
| The role of b-interferon plus melphalan and prednisolone in untreated patients with multiple myeloma |
| NAHİDE KONUK, BEKİR YAZAN, İSMET AYDOĞDU |
| Department of Hematology, Internal Medicine, Ankara University Medical School, Ankara-Turkey |
Fifteen previously untreated myeloma patients received b-interferon (b-lFN) plus melphalan (M) and prednisolone (P) for induction. Overall response rate was 79% which includes complete remission 20% and partial remission 33%. Side effects of b-IFN were not dose-limiting. Median survival was 13 months. Both the non responders and patients with minimal response had symptomatic improvement. We concluded that combining b-IFN with melphalan (M) and prednisolone (P) can produce improved response rates over standard MP therapy.
|
|
[ Summary ]
|
Turkish Journal of Cancer web sitesi Novartis Onkoloji'nin karşılıksız eğitim katkılarıyla hazırlanmıştır.
|
